Table 1 Participant characteristics of treatment groups in the inflammation cohort
From: Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants
Controls | EVC001 | P value | |
|---|---|---|---|
Treatment | 20 | 20 | |
Home births | 1 | 2 | 0.595 |
Hours in labor | 18.11 (24.3) | 10.94 (9.93) | 0.574 |
Cesarean births | 8 | 3 | 0.160 |
Antibiotics during labor | 8 | 7 | 0.213 |
Gestation (weeks) | 39.76 (1.13) | 39.51 (1.13) | 0.491 |
Females | 11 | 11 | 0.752 |
Baby birth weight (g) | 3555.74 (723.58) | 3411.23 (338.65) | 0.930 |
Baby discharged weight (g) | 3324.65 (675.18) | 3209.33 (379.47) | 0.912 |
Baby birth length (cm) | 50.54 (3.37) | 50.31 (2.09) | 0.724 |
Baby received antibiotics | 1 | 0 | 1 |
Baby birth medical complications | 3 | 0 | 0.232 |
Consumed infant formula before discharge | 1 | 0 | 1 |
Maternal pre-pregnancy BMI calculated | 23.538 (3.53) | 25.610 (3.45) | 0.059 |
Maternal pregnancy weight gain (kg) | 15.33 (5.07) | 13.940 (5.86) | 0.66 |
Maternal GBS test positive | 5 | 6 | 0.724 |
Primaparous | 17 | 7 | 0.006 |
Maternal age | 30.9 (3.42) | 34.7 (3.97) | 0.004 |
